| 摘要 |
The present invention relates to a process for preparing a compound of the formula I or a pharmaceutically acceptable salt, prodrug, hydrate or solvate thereof, wherein R<1>, R<2>, R<3 >and R<4 >are as defined herein. The compound of formula I is useful in the treatment of abnormal cell growth, such as cancer, in mammals.
|
